MedTrace Logo

Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients

NCT03003507 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2016-12-28

No results posted yet for this study

Summary

Hyperglycemia is a known risk factor for mortality in critically ill patients. Most of these patients receive enteral feeding. There is controversy about ideal carbohydrate composition of these diets. The aim of this study was to compare an enteral formula with the same proportion of carbohydrates with and without fructose on blood glucose levels.

Conditions

  • Critical Illness

Interventions

DIETARY_SUPPLEMENT

Enteral Formula With Fructose

Low-carbohydrate Enteral Formula With Fructose

DIETARY_SUPPLEMENT

Enteral Formula Without Fructose

Low-carbohydrate Enteral Formula Without Fructose

Sponsors & Collaborators

  • Hospital Moinhos de Vento

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-04-30
Completion
2013-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03003507 on ClinicalTrials.gov